bioAffinity Technologies, Inc. Balance Sheet
BIAF|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
bioAffinity Technologies, Inc. had $11M in total assets and $3M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $6.4M | $1.1M | $2.8M | $11.4M |
| Inventory | $53.5K | $27.6K | $18.5K | $5.5K |
| Current Assets | $7.6M | $2.7M | $4.0M | $12.0M |
| PP&E (Net) | $265.6K | $375.4K | $458.6K | $214.4K |
| Goodwill | $1.4M | $1.4M | $1.4M | - |
| Total Assets | $11.0M | $6.5M | $8.2M | $12.2M |
| Current Liabilities | $2.9M | $3.1M | $2.2M | $1.1M |
| Shareholders' Equity | $2.6M | $4.9M | $11.0M | -$15.8M |